Kara Boothby, PA
Physician Assistant · Wasilla, AKNPI 1356999189
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$923
- AstraZeneca$832
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$714
- GSK$586
- Novo Nordisk$429
- Pfizer$170
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $923 |
| AstraZeneca | 43 | $832 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $714 |
| GSK | 31 | $586 |
| Novo Nordisk | 20 | $429 |
| Pfizer | 10 | $170 |
| Novartis | 7 | $160 |
| Nestle Healthcare Nutrition Inc. | 7 | $153 |
| Amgen | 6 | $150 |
| Exact Sciences | 5 | $121 |
| Aimmune Therapeutics, Inc. | 4 | $104 |
| Merck | 7 | $94 |
| E.r. Squibb & Sons, L.L.C. | 4 | $82 |
| Lilly USA, LLC | 4 | $82 |
| Kowa Pharmaceuticals America, Inc. | 4 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $68 |
| Biohaven Pharmaceuticals, Inc. | 4 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Digestive Care, Inc. | 1 | $39 |
| Alkermes, Inc. | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $35 |
| Eisai Inc. | 2 | $35 |
| Medicure Pharma Inc. | 1 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Electromed, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Echosens North America, Inc. | 1 | $20 |
| Medtronic | 1 | $20 |
| Radius Health, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
How this compares
$5,327 in reported general payments places this provider in the 95th percentile of 365 physician assistant providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $27,050 |
| VraylarCariprazine Hcl | 13 | $26,870 |
| MounjaroTirzepatide | 12 | $19,088 |
| FarxigaDapagliflozin Propanediol | 14 | $18,335 |
| OzempicSemaglutide | 13 | $14,387 |
| SynthroidLevothyroxine Sodium | 21 | $2,326 |
| Atorvastatin Calcium | 94 | $1,026 |
| Esomeprazole Magnesium | 14 | $988 |
| Omeprazole | 60 | $873 |
| Rosuvastatin Calcium | 51 | $859 |
| Lisinopril | 84 | $580 |
| Levothyroxine Sodium | 65 | $563 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $553 |
| Amlodipine Besylate | 60 | $526 |
| Losartan Potassium | 50 | $447 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Synthroid | $923 | $29,19634 claims |
| GSKTrelegy Ellipta | $586 | $27,05025 claims |
| Lilly USA, LLCMounjaro | $82 | $19,08812 claims |
| AstraZenecaFarxiga | $832 | $18,33514 claims |
| Novo NordiskOzempic | $429 | $14,38713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 365 physician assistant providers in Alaska.
Other physician assistant in Wasilla
- Donald SmithWasilla$6K
- Jennifer McLaughlinWasilla$4K
- Vincent PerinoWasilla$2K
- David TheuretWasilla$1K
- Andrew MerrickWasilla$1K
- Jeremy RosieckiAnchorage$93K
- Ivy ParayoAnchorage$12K
- Shannon DieffenderferAnchorage$11K
- Zach ZipsirAnchorage$8K
- James LafleurFairbanks$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.